Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 04:00:02 2024-04-18 pm EDT			5-day change	1st Jan Change
125.2 ^USD	-0.13%		-0.75%	+14.85%

Apr. 15	Zacks Adjusts Price Target on Merck & Company to $132 From $128	MT
Apr. 11	Merck & Co Receives a Shareholder Proposal from The Bahnsen Family Trust	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zacks Adjusts Price Target on Merck & Company to $132 From $128	Apr. 15	MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating	Apr. 08	MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating	Mar. 27	MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating	Mar. 27	MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103	Mar. 11	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
UBS Adjusts Merck & Co.'s Price Target to $148 From $135, Maintains Buy Rating	Feb. 02	MT
Wells Fargo Raises Merck's Price Target to $130 From $125, Maintains Equalweight Rating	Feb. 02	MT
Truist Securities Raises Merck's Price Target to $139 From $122, Maintains Buy Rating	Feb. 02	MT
Goldman Sachs Raises Merck's Price Target to $134 From $128, Maintains Buy Rating	Feb. 02	MT
Barclays Raises Merck's Price Target to $145 From $135, Keeps Overweight Rating	Feb. 02	MT
Jefferies Raises Merck's Price Target to $140 From $136, Keeps Buy Rating	Feb. 02	MT
Did you expect anything different?	Feb. 01
Futures climb following Wall St selloff after Fed holds rates steady	Feb. 01	RE
Deutsche Bank Adjusts Merck & Company Price Target to $135 From $115, Maintains Buy Rating	Jan. 29	MT
BofA Securities Raises Merck Price Target to $135 From $130, Maintains Buy Rating	Jan. 26	MT
Barclays Raises Merck's Price Target to $135 From $130, Maintains Overweight Rating	Jan. 23	MT
UBS Adjusts Merck & Company Price Target to $135 From $122, Maintains Buy Rating	Jan. 17	MT
TD Cowen Upgrades Merck to Outperform From Market Perform, Raises Price Target to $135 From $125	Jan. 04	MT
Euphoria subsides for Triple-Witching Day	Dec. 15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters